Improvement of gastrointestinal symptoms after conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium in liver transplant patients.
about
Impact of switching from mycophenolate mofetil to enteric-coated mycophenolate sodium on gastrointestinal side effects in patients with autoimmune disease: a Phase III, open-label, single-arm, multicenter studyThe evaluation of enteric-coated mycophenolate sodium in cardiac deceased donor liver transplant patients in China.
P2860
Improvement of gastrointestinal symptoms after conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium in liver transplant patients.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Improvement of gastrointestina ...... in liver transplant patients.
@en
Improvement of gastrointestina ...... in liver transplant patients.
@nl
type
label
Improvement of gastrointestina ...... in liver transplant patients.
@en
Improvement of gastrointestina ...... in liver transplant patients.
@nl
prefLabel
Improvement of gastrointestina ...... in liver transplant patients.
@en
Improvement of gastrointestina ...... in liver transplant patients.
@nl
P2093
P2860
P1476
Improvement of gastrointestina ...... in liver transplant patients.
@en
P2093
Alexander H Toledo
Courtney Smith
David A Gerber
Erin Fisher
Kimberly Newton
Laura Hendrix
Valorie Buchholz
P2860
P304
P356
10.1111/J.1399-0012.2011.01444.X
P577
2011-04-07T00:00:00Z